18F-FDG PET显像中的肝脏超级扫描:一项系统综述
该系统综述纳入38项研究共40例患者,分析18F-FDG PET上肝脏超级扫描的病因、临床与预后意义;作者建立视觉评分系统VSS-HS,多数患者为VSS-HS3(n=28),中位随访29天死亡16例,1年总生存率42.3%,病因和VSS-HS与总生存相关。
要点
- 肝脏超级扫描表现为肝脏弥漫性FDG摄取增高,VSS-HS3最常见(n=28)。
- 病因包括血液系统恶性肿瘤、感染、暴发性转移、代谢性疾病、药物性肝毒性等。
- 中位随访29天死亡16例,1年总生存率42.3%,血液系统恶性肿瘤和暴发性转移病死率最高。
核心结论
- 肝脏超级扫描是独特的分子影像模式,其临床意义和预后价值需进一步研究。
研究设计与样本
- 系统综述,检索PubMed、Web of Science和Scopus数据库至2024年3月4日,纳入38项研究共40例患者,作者开发VSS-HS视觉评分系统进行分子影像特征分析,采用Kaplan-Meier曲线、log-rank检验和Cox比例风险分析,p<0.05为有统计学意义。
关键影像表现/征象
- 多数患者表现为肝脏强烈高代谢(VSS-HS3,n=28)。
- 病因包括血液系统恶性肿瘤、感染、暴发性转移、代谢性疾病、药物性肝毒性、多发性肿瘤和肝脏肿瘤。
- 临床表现多样,70%表现为乏力,57%表现为急性肝衰竭征象。
诊断标准与关键数值
- 作者开发的VSS-HS视觉评分系统用于分子影像特征分析,VSS-HS3表示肝脏强烈高代谢(n=28)。
- 单因素分析显示VSS-HS和病因因素均显著影响总生存(各p<0.04),多因素分析中病因因素仍显著(p=0.001)。
- 药物性肝毒性和暴发性转移的病因特异性病死率超过62%。
局限性
- 原文结论指出需进一步研究以理解肝脏超级扫描的临床意义和预后价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: This systematic review examines hepatic superscan on [18F]fluorodeoxyglucose ([18F]FDG) positron emission tomography (PET) imaging, investigating its clinical and prognostic implications. METHODS: PubMed, Web of Science, and Scopus databases were used to conduct a systematic search and were updated until March 4, 2024. A visual scoring system (VSS-HS) was developed by the authors for molecular imaging feature analysis. Survival analysis was performed via Kaplan‒Meier curves, log-rank tests, and Cox proportional hazard analyses, with p values < 0.05 indicating statistical significance. RESULTS: The review identified 38 eligible studies with 40 patients from the PubMed, Scopus, and Web of Science databases. Etiologic factors included hematologic malignancies, infections, fulminant metastases, metabolic disorders, drug-induced hepatotoxicity, multiple neoplasia, and hepatic neoplasm. The clinical manifestations vary, with 70% presenting with fatigue and 57% presenting with acute liver failure signs. Most patients exhibited intense hepatic hypermetabolism (VSS-HS3, n = 28). Sixteen patients died during a median 29-day follow-up, with a 1-year overall survival of 42.3%. Fatalities are most common in patients with hematologic malignancies and fulminant metastases. Drug-induced hepatotoxicity and fulminant metastases have high etiology-specific mortality rates, exceeding 62%. Univariate analysis revealed that VSS-HS and etiologic factors significantly influenced overall survival (p < 0.04 each) with the latter remained significant in multivariate analysis (p = 0.001). CONCLUSION: Hepatic superscan is a unique molecular imaging pattern, and further investigation is needed to understand its clinical implications and prognostic value.
引用
- Saad Abdlkadir A, Al-Adhami D, Lopci E, et al. Hepatic superscan on [18F]FDG PET imaging: a systematic review. Abdom Radiol (NY). 2025. PMID: 41165783. doi:10.1007/s00261-025-05186-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。